Back
Curis Vs. Armata Pharmaceuticals Industry Stock Comparison
Sell
35
CRIS
Curis
Last Price:
3.51
Seasonality Move:
5.02%
Buy
53
ARMP
Armata Pharmaceuticals
Last Price:
2.15
Seasonality Move:
5.16%
Sell
35
Curis (CRIS)
is a Sell
Is Curis a Buy, Sell or Hold?
- The current Curis [CRIS] share price is $3.57. The Score for CRIS is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- CRIS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Armata Pharmaceuticals (ARMP)
is a Buy
Is Armata Pharmaceuticals a Buy, Sell or Hold?
- The current Armata Pharmaceuticals [ARMP] share price is $2.19. The Score for ARMP is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- ARMP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CRIS Stock Price Chart
ARMP Stock Price Chart
What is Armata Pharmaceuticals's stock price today?
-
The Armata Pharmaceuticals share price today is $2.19
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARMP is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRIS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.18 | Sell |
| Relative Strength Index (14 RSI): | 35.24 | Sell |
| Chaikin Money Flow: | -24138 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.79 - 4.25) | Sell |
| Bollinger Bands (100): | (4.16 - 5.6) | Sell |
ARMP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 46.97 | Sell |
| Chaikin Money Flow: | 2097 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.08 - 2.46) | Sell |
| Bollinger Bands (100): | (2.18 - 2.58) | Sell |
CRIS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.88 | Sell |
| 20-day SMA: | 3.99 | Sell |
| 50-day SMA: | 4.47 | Sell |
| 200-day SMA: | 7.97 | Sell |
| 8-day EMA: | 3.85 | Sell |
| 20-day EMA: | 4.02 | Sell |
| 50-day EMA: | 4.43 | Sell |
| 200-day EMA: | 7.06 | Sell |
ARMP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.18 | Buy |
| 20-day SMA: | 2.2 | Sell |
| 50-day SMA: | 2.3 | Sell |
| 200-day SMA: | 2.71 | Sell |
| 8-day EMA: | 2.18 | Buy |
| 20-day EMA: | 2.22 | Sell |
| 50-day EMA: | 2.29 | Sell |
| 200-day EMA: | 2.55 | Sell |
Curis Earnings Growth & CRIS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.36 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.35 per share, and an increase next year of $3.00 per share.
Armata Pharmaceuticals Earnings Growth & ARMP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and an increase next year of $0.52 per share.
Curis Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Armata Pharmaceuticals Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||